|
HY-101372A-5mg
|
MedChemexpress LLC
|
Oxotremorine M (iodide) [CAS 3854-04-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-101372A-50mg
|
MedChemexpress LLC
|
Oxotremorine M (iodide) [CAS 3854-04-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-103164-10mg
|
MedChemexpress LLC
|
(E)-8-(3-Chlorostyryl)caffeine [CAS 147700-11-6]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-103164-5mg
|
MedChemexpress LLC
|
(E)-8-(3-Chlorostyryl)caffeine [CAS 147700-11-6]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-103661-10mg
|
MedChemexpress LLC
|
BI-6C9 [CAS 791835-21-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103661-5mg
|
MedChemexpress LLC
|
BI-6C9 [CAS 791835-21-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103661-50mg
|
MedChemexpress LLC
|
BI-6C9 [CAS 791835-21-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-107209-5mg
|
MedChemexpress LLC
|
RKI-1313 [CAS 1342276-76-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-107411-10mg
|
MedChemexpress LLC
|
Bromoenol lactone [CAS 88070-98-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-107411-100mg
|
MedChemexpress LLC
|
Bromoenol lactone [CAS 88070-98-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-107411-25mg
|
MedChemexpress LLC
|
Bromoenol lactone [CAS 88070-98-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-107411-5mg
|
MedChemexpress LLC
|
Bromoenol lactone [CAS 88070-98-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-107411-50mg
|
MedChemexpress LLC
|
Bromoenol lactone [CAS 88070-98-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-108511-10mg
|
MedChemexpress LLC
|
PB28 (dihydrochloride) [CAS 172907-03-8]
|
|
COVID-19-anti-virus
|
|
|
HY-108511-100mg
|
MedChemexpress LLC
|
PB28 (dihydrochloride) [CAS 172907-03-8]
|
|
COVID-19-anti-virus
|
|
|
HY-108511-25mg
|
MedChemexpress LLC
|
PB28 (dihydrochloride) [CAS 172907-03-8]
|
|
COVID-19-anti-virus
|
|
|
HY-108511-5mg
|
MedChemexpress LLC
|
PB28 (dihydrochloride) [CAS 172907-03-8]
|
|
COVID-19-anti-virus
|
|
|
HY-108511-50mg
|
MedChemexpress LLC
|
PB28 (dihydrochloride) [CAS 172907-03-8]
|
|
COVID-19-anti-virus
|
|
|
HY-108608-10mg
|
MedChemexpress LLC
|
o-3M3FBS [CAS 313981-55-4]
|
|
|
|
|
HY-108608-25mg
|
MedChemexpress LLC
|
o-3M3FBS [CAS 313981-55-4]
|
|
|
|
|
HY-108608-5mg
|
MedChemexpress LLC
|
o-3M3FBS [CAS 313981-55-4]
|
|
|
|
|
HY-108608-50mg
|
MedChemexpress LLC
|
o-3M3FBS [CAS 313981-55-4]
|
|
|
|
|
HY-109008-10mg
|
MedChemexpress LLC
|
Nacubactam [CAS 1452458-86-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-109008-100mg
|
MedChemexpress LLC
|
Nacubactam [CAS 1452458-86-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-109008-5mg
|
MedChemexpress LLC
|
Nacubactam [CAS 1452458-86-4]
|
|
COVID-19-immunoregulation
|
|
